Skip to main content
OpenTrials

Clinical trial condition

Unresectable Melanoma

Explore clinical trials studying Unresectable Melanoma. Study availability and eligibility vary by location and protocol.

52 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Melanoma trial results

Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT05136196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 225 locations
View Trial Details
Recruiting

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

NCT05727904

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations
  • University of Alabama at Birmingham: The Kirklin Clinic Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 81 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

NCT06940739

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +17 more
Locations
  • SCRI Oncology Partners- Denver Denver, Colorado, United States
  • UNC Hospitals, The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Greenslopes Private Hospital Greenslopes, Queensland, Australia
View Trial Details
Recruiting

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

NCT05896839

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +34 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 26 locations
View Trial Details
Recruiting

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

NCT05361174

Conditions
Bronchial Diseases, Bronchial Neoplasms, Carcinoma, +24 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Recruiting

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

NCT06624644

Conditions
Cutaneous Melanoma, Melanoma, Melanoma (Skin Cancer), +13 more
Locations
  • USC Newport Beach Newport Beach, California, United States
  • UCSF San Francisco, California, United States
  • Stanford Stanford, California, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
View Trial Details

Related conditions